Vestibular Migraine With Brainstem Auras: A Review of Pathogenesis, Clinical Varieties, Abortive and Prophylactic Treatment | Zhang | Journal of Neurology Research
Source : https://www.neurores.org/index.php/neurores/article/view/651/668
Vestibular Migraine With Brainstem Auras: A Review of Pathogenesis, Clinical Varieties, Abortive and Prophylactic Treatment Ai Juan Zhang a, Ai Yuan Zhang b, d, Lin Zhi Gao c, Li Zhou...
-
Huma Sheikh, CEO, NY Neurology Medicine, PC4yrSuch a difficult condition to treat.
Effectiveness and safety of erenumab and galcanezumab in the prevention of chronic and episodic migraine: a retrospective cohort study
Source : https://www.authorea.com/doi/full/10.22541/au.163510326.65694933
Effectiveness and safety of erenumab and galcanezumab in the prevention of chronic and episodic migraine: a retrospective cohort study Adrián Viudez-Martinez , Angela Pascual-Carrasco, Isabel Beltrán Blasco, Raquel Hernandez-Lorido, Rosa...
-
Huma Sheikh, CEO, NY Neurology Medicine, PC4yrGreat to see more validation of the new cGRP inhibitors.
Highlights
- Children and adolescents with ASD are predisposed to migraine development.
- ASD is an independent risk factor for migraine, regardless of the psychiatric and medical comorbidities involved.
- Especially, male patients with ASD had a significantly higher risk of developing migraine relative to the non-ASD controls.
-
Huma Sheikh, CEO, NY Neurology Medicine, PC4yrInteresting.
Classifying migraine subtypes and their characteristics by latent class analysis using data of a nation-wide population-based study - Scientific Reports
Source : https://www.nature.com/articles/s41598-021-01107-7
Migraine neither presents with a definitive single symptom nor has a distinct biomarker; thus, its diagnosis is based on combinations of typical symptoms. We aimed to identify natural subgroups of...
In conclusion, LCA is useful for analyzing the heterogeneity of migraine symptoms and identifying migraine subtypes. This approach may improve our understanding of the clinical characterization of migraine.
-
Huma Sheikh, CEO, NY Neurology Medicine, PC4yrHopefully we can use classifications like this to help guide treatment.
Efficacy and safety of erenumab in migraine prevention: evidences from direct and indirect comparisons - Neurological Sciences
Source : https://link.springer.com/article/10.1007/s10072-021-05701-5
Background To date, it remains challenging for clinicians to make informed decisions about which dosage of erenumab is more effective for treating adult patients with migraine. Thus, we sought to...
Conclusions: The results from this study suggested erenumab 140 mg might provide better efficacy than 70 mg among adult patients with migraine, without increasing TEAEs. Future elaborated RCTs with a larger number of participants are warranted to validate these discoveries.
-
Huma Sheikh, CEO, NY Neurology Medicine, PC4yrGreat to see that it is effective.